LAWYER PROFILE
Daniel Brook

Daniel Brook

UK 2026

Chambers ranking badge
Share profile
Chambers ranking badge
Hogan Lovells Cadwalader
 Hogan Lovells Cadwalader

Ranked in 2 practice areas

Life Sciences: IP/Patent Litigation

UK-wide

4 years ranked

Intellectual Property: Patent Litigation

London (Firms)

13 years ranked

About

Provided by Hogan Lovells Cadwalader

Practice Areas

Intellectual Property

Patents

Life Sciences and Healthcare

Pharmaceuticals and Biotechnology

Career

Please see https://www.hoganlovells.com/en/daniel-brook for further information.

Professional Memberships

AIPPI Council Member

CIPA

EPLAW

Work Highlights

- Acting for MSD in relation to patent challenges around its products including simvastatin, lovastatin, alendronate and raltegravir.

- Acting for Lilly in relation to patent challenges around its oncology products including pemetrexed (Supreme Court) and gemcitabine.

- Acting for BMS in relation to patent challenges around its products, dasatinib, efavirenz and atazanavir.

- Acting for a number of electronic clients including HTC, ZTE and BlackBerry on European patent litigation matters.

Experience

Daniel is a patent litigator in the UK. He acts for clients such as MSD, Lilly, Amgen and BMS. Recent key cases include Actavis v Lilly (Supreme Court), Schutz v Werit (Supreme Court), and BMS v Teva (availability of interim injunctions).

He has experience with each of the major patent jurisdictions in Europe. He regularly manages cross border patent litigation for clients on their most important products and has been involved in a number of leading cases.

Daniel is ranked by Chambers UK - 'Clients commend his 'high-quality counselling' and his 'clear, well-structured' communications.', Legal 500, MIP IP Stars, IAM Patent 1000 and Who's Who Legal.

Key sectors

Health and Life SciencesTechnology, Media and Telecoms (TMT)

Chambers Review

Provided by Chambers

Chambers Guide to the Legal Profession

Life Sciences: IP/Patent Litigation - UK-wide

Band 2
Individual Editorial

Daniel Brook is highly recommended for his strong practice in patent litigation, which sees him regularly advise and act for significant clients in the pharmaceutical space.

Learn more about this teamView ranking table

Intellectual Property: Patent Litigation - London (Firms)

Band 2
Individual Editorial
Daniel Brook frequently litigates complex cross-border patent disputes for large corporates in the life sciences and pharmaceutical industries. He also has experience representing aviation and engineering firms in patent litigation.
Learn more about this teamView ranking table

Strengths

Provided by Chambers

  • Dan is excellent; he does a lot of litigation and is well regarded by pharma innovator clients.

    Life Sciences: IP/Patent LitigationChambers Guide to the Legal Profession

  • Daniel Brook is a standout lawyer for biosimilars litigation.

    Life Sciences: IP/Patent LitigationChambers Guide to the Legal Profession

  • Daniel Brook is such a clever litigator, incredibly good on the tech side, and very well respected.

    Intellectual Property: Patent LitigationChambers Guide to the Legal Profession

  • Dan is brilliant. He has an enormous amount of knowledge about the pharma sector and his clients' businesses so is able to frame litigation with real commercial awareness as well as legal knowledge.

    Intellectual Property: Patent LitigationChambers Guide to the Legal Profession

  • We found Daniel Brook to be incredibly clever and helpful.

    Intellectual Property: Patent LitigationChambers Guide to the Legal Profession

Ranked Individuals at Hogan Lovells Cadwalader (148)

London (Firms)

What success is built on

Chambers is the leading data and intelligence partner for the legal sector.

Explore thought leadership